Success of $4 generic programs highlights potential consumerism
By William Pollock
01 February 2009
This Milliman white paper examines the huge success of Wal-Mart's decision to sell a 30-day supply of some common generic drugs at just $4. As retailers become more aggressive with drug pricing, retail drug prices can vary greatly. The author recommends plan sponsors help their participants find the lowest price available for their medications, and offer incentives for doing so.
About the Author(s)
William Pollock
Success of $4 generic programs highlights potential consumerism
This Milliman white paper examines the huge success of Wal Mart's decision to sell a 30 day supply of some common generic drugs at just $4. As retailers become more aggressive with drug pricing, retail drug prices can vary greatly.
William Pollock